Heinrich-Ferdinand Moeschler

Title: Heinrich-Ferdinand Moeschler: Innovator in Nikkomicin Concentration

Introduction

Heinrich-Ferdinand Moeschler is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of biochemistry, particularly in the concentration of nikkomicins. His innovative approach has led to advancements in the purification processes of these important compounds.

Latest Patents

Moeschler holds a patent for a process titled "Concentrating nikkomicin mixtures." This patent describes a method for concentrating nikkomicins (X) and (Z) from a dilute impure aqueous solution. The process involves contacting the solution with a weakly basic ion exchanger and eluting the adsorbed material with an acid. This results in a concentrated mixture of nikkomicin (X) and nikkomicin (Z). The method can utilize a filtered microbial cultivation liquor or a prepurified liquor treated with an acid ion exchanger followed by elution with a base. The recovered material is noted for its relatively high purity.

Career Highlights

Heinrich-Ferdinand Moeschler is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to explore and develop innovative solutions in biochemistry, contributing to the company's reputation for excellence in research and development.

Collaborations

Throughout his career, Moeschler has collaborated with esteemed colleagues, including Christian Golker and Peter M Lange. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Heinrich-Ferdinand Moeschler's contributions to the field of nikkomicin concentration exemplify the impact of innovative thinking in biochemistry. His patent and work at Bayer Aktiengesellschaft highlight the importance of research and collaboration in advancing scientific knowledge.